HilleVax Inc.

NAS: HLVX

GO
/marketstate/country/us

Market open

 --Quotes are delayed by 20 min

Oct 4, 2022, 11:14 a.m.

/zigman2/quotes/234952647/composite

$

17.94

Change

-0.39 -2.13%

Volume

Volume 4,322

Quotes are delayed by 20 min

/zigman2/quotes/234952647/composite

Previous close

$ 18.33

$ 17.94

Change

-0.39 -2.13%

Day low

Day high

$17.31

$18.59

Open

52 week low

52 week high

$7.90

$24.42

Open

Julie Louise Gerberding

Julie Louise Gerberding is Chief Executive Officer & Director at Foundation for the National Institutes of Health, Inc., Member of National Academy of Public Administration and Member of National Academy of Medicine (United States) and on the board of 7 other companies.

She previously held the position of Chief Patient Officer & EVP-Communication at Merck & Co., Inc. Co-Chairman for MSD Vaccines Ltd. and President for Merck Vaccine Division (both are subsidiaries of Merck & Co., Inc.) and Director at Centers for Disease Control & Prevention.

Dr. Gerberding received a doctorate and an undergraduate degree from Case Western Reserve University and a graduate degree from the University of California, Berkeley.

Transactions

Date Shares Transaction Value

Officers and Executives

Dr. Robert M. Hershberg
Chairman, President & Chief Executive Officer
Dr. Aditya Kohli
Chief Operating Officer & Director
Mr. David A. Socks
Chief Financial & Business Officer
Dr. Astrid Borkowski
Chief Medical Officer
Mr. Paul S. Bavier
Secretary & Chief Administrative Officer
Dr. Gary Dubin
Director
Ms. Kaia Agarwal
Senior Vice President-Regulatory Affairs
Dr. Shelley Chu
Independent Director
Dr. Julie Louise Gerberding
Independent Director
Mr. Patrick J. Heron
Independent Director
Ms. Jeryl Lynn Hilleman
Independent Director
Dr. Jaime Sepulveda
Independent Director
Ms. Susan Silbermann
Independent Director
Link to MarketWatch's Slice.